EUVIMEDEUVIMED entdecken
Crossref

Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2− Breast Cancer With cN0

Yong Min Na, Sang Chun Park, Young Jae Ryu, Jin Seong Cho, Min Ho Park

Anticancer Research · 2024

DOI: 10.21873/anticanres.17169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Yong Min Na und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Chonnam National University Medical School & Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphatic Metastasis, Erb-b2 Receptor Tyrosine Kinases, Sentinel Lymph Node.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: This study aimed to identify the risk factors associated with non-sentinel lymph node (non-SLN) metastasis in case of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer with cN0 on preoperative exam, where the sentinel lymph node (SLN) is positive. PATIENTS AND METHODS: We conducted a retrospective review of medical records from the Chonnam National University Hwasun Hospital, spanning from January 2013 to January 2020, focusing on patients with HR+, HER2- breast cancer. Specifically, we collected the clinical and pathological data for those patients who underwent axillary lymph node dissection (ALND) due to positive SLN. RESULTS: Among the 166 patients who underwent ALND after positive SLNs, median patient age was 52 years. Univariate analyses demonstrated a significant association between non-SLN metastasis and the number of positive SLNs (p=0.039), SLN positive ratio (p 0.55 (p=0.004, HR=3.007, 95% CI=1.427-6.335) was independently associated with non-SLN metastasis. However, neither the number of positive SLN nor primary tumor size showed associations with non-SLN metastases. CONCLUSION: In patients with HR+, HER2- breast cancer who are cN0, completion of ALND should be considered when the positive SLN ratio is ≥0.55. This approach aims to provide the opportunity for survival benefit through additional adjuvant therapy or to contribute to de-escalation of unnecessary surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymphatic MetastasisErb-b2 Receptor Tyrosine KinasesSentinel Lymph NodeHumansFemaleMiddle AgedRisk FactorsAdultRetrospective StudiesAgedLymph Node ExcisionReceptors, EstrogenReceptors, ProgesteroneSentinel Lymph Node BiopsyAxillaLymph Nodes

Stichwörter der Autor:innen

Breast cancernon-sentinel lymph noderisk factorsentinel lymph node biopsy

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneERBB2 protein, human

Autor:innen und Institutionen

  • Department of Surgery, Chonnam National University Medical School & Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea.
  • Department of Surgery, Chonnam National University Medical School & Chonnam National University Hospital, Gwang-ju, Republic of Korea.
  • Department of Surgery, Chonnam National University Medical School & Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea; mhpark@chonnam.ac.kr.

Zitieren

APA

Na, Y. M., Park, S. C., Ryu, Y. J., Cho, J. S., & Park, M. H. (2024). Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2− Breast Cancer With cN0. Anticancer Research. https://doi.org/10.21873/anticanres.17169

Vancouver

Na YM, Park SC, Ryu YJ, Cho JS, Park MH. Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2− Breast Cancer With cN0. Anticancer Research. 2024. doi:10.21873/anticanres.17169

BibTeX
@article{Na2024,
  author = {Na, Yong Min and Park, Sang Chun and Ryu, Young Jae and Cho, Jin Seong and Park, Min Ho},
  title = {Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2− Breast Cancer With cN0},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17169}
}
Kostenlos starten →